ABO1108

BIOLOGICAL3 trials

Sponsors

Suzhou Abogen Biosciences Co., Ltd.

Conditions

Varicella-zoster Virus

Phase 1

Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Active, not recruitingNCT07285265

Suzhou Abogen Biosciences Co., Ltd.Varicella-zoster Virus

Start: 2025-05-27End: 2026-10-15Updated: 2026-05-11

Phase 2

Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Active, not recruitingNCT07285278

Suzhou Abogen Biosciences Co., Ltd.Varicella-zoster Virus

Start: 2025-11-15End: 2027-02-15Target: 300Updated: 2026-05-11

Phase 3

Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

RecruitingNCT07817108

Suzhou Abogen Biosciences Co., Ltd.Varicella-zoster Virus

Start: 2026-06-27End: 2027-10-17Target: 18000Updated: 2026-09-14